Stock listing
KRX:034940 ChoA Pharmaceutical Co., Ltd. (조아제약) 주가
Follow ChoA Pharmaceutical Co., Ltd. into a list and get an email when it puts out news.
Share price · KRX:034940
₩1,422.00 KRW -38.00 (-2.6%)
Close on Nov 20, 2026
- Day range
- ₩1,393.00 – ₩1,526.00 KRWNov 20, 2026
- Volume
- 14,785 sharesNov 20, 2026
- Market cap
- ₩8.81B KRWAt the close on Nov 20, 2026 · price × 6.20M shares outstanding
- 52-week range
- ₩1,342.00 – ₩5,865.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩362.3M KRWMedian day 40,523 shares · last 3 months, Aug 27, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 27, 2026 – Nov 20, 2026 · KRX:034940 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩1,422.00 | -38.00 | -2.6% | ₩1,450.00 | ₩1,526.00 | ₩1,393.00 | 14,785 | |
| ₩1,460.00 | +62.00 | +4.4% | ₩1,417.00 | ₩1,510.00 | ₩1,388.00 | 24,584 | |
| ₩1,398.00 | -20.00 | -1.4% | ₩1,418.00 | ₩1,424.00 | ₩1,342.00 | 10,962 | |
| ₩1,418.00 | -68.00 | -4.6% | ₩1,486.00 | ₩1,501.00 | ₩1,400.00 | 12,902 | |
| ₩1,486.00 | -22.00 | -1.5% | ₩1,508.00 | ₩1,528.00 | ₩1,452.00 | 12,199 | |
| ₩1,508.00 | +2.00 | +0.1% | ₩1,516.00 | ₩1,593.00 | ₩1,495.00 | 11,006 | |
| ₩1,506.00 | +28.00 | +1.9% | ₩1,477.00 | ₩1,608.00 | ₩1,405.00 | 32,114 | |
| ₩1,478.00 | -46.00 | -3.0% | ₩1,526.00 | ₩1,587.00 | ₩1,417.00 | 19,609 | |
| ₩1,524.00 | -42.00 | -2.7% | ₩1,566.00 | ₩1,587.00 | ₩1,500.00 | 11,890 | |
| ₩1,566.00 | -44.00 | -2.7% | ₩1,586.00 | ₩1,604.00 | ₩1,515.00 | 17,682 | |
| ₩1,610.00 | 0.00 | 0.0% | ₩1,609.00 | ₩1,755.00 | ₩1,609.00 | 31,154 | |
| ₩1,610.00 | +30.00 | +1.9% | ₩1,580.00 | ₩1,611.00 | ₩1,550.00 | 9,996 | |
| ₩1,580.00 | -105.00 | -6.2% | ₩1,684.00 | ₩1,684.00 | ₩1,516.00 | 43,229 | |
| ₩1,685.00 | -19.00 | -1.1% | ₩1,704.00 | ₩1,704.00 | ₩1,640.00 | 15,724 | |
| ₩1,704.00 | -4.00 | -0.2% | ₩1,610.00 | ₩1,769.00 | ₩1,610.00 | 31,604 | |
| ₩1,708.00 | -63.00 | -3.6% | ₩1,773.00 | ₩1,773.00 | ₩1,604.00 | 40,435 | |
| ₩1,771.00 | -79.00 | -4.3% | ₩1,834.00 | ₩1,870.00 | ₩1,751.00 | 39,815 | |
| ₩1,850.00 | +15.00 | +0.8% | ₩1,850.00 | ₩1,958.00 | ₩1,811.00 | 42,721 | |
| ₩1,835.00 | -11.00 | -0.6% | ₩1,846.00 | ₩1,888.00 | ₩1,817.00 | 15,740 | |
| ₩1,846.00 | -37.00 | -2.0% | ₩1,883.00 | ₩1,951.00 | ₩1,810.00 | 37,159 | |
| ₩1,883.00 | -104.00 | -5.2% | ₩1,922.00 | ₩2,000.00 | ₩1,850.00 | 78,939 | |
| ₩1,987.00 | -78.00 | -3.8% | ₩2,005.00 | ₩2,075.00 | ₩1,805.00 | 48,502 | |
| ₩2,065.00 | -130.00 | -5.9% | ₩2,190.00 | ₩2,190.00 | ₩2,055.00 | 20,824 | |
| ₩2,195.00 | +65.00 | +3.1% | ₩2,010.00 | ₩2,195.00 | ₩2,010.00 | 32,791 | |
| ₩2,130.00 | -70.00 | -3.2% | ₩2,025.00 | ₩2,145.00 | ₩1,935.00 | 133,115 | |
| ₩2,200.00 | -90.00 | -3.9% | ₩2,245.00 | ₩2,290.00 | ₩2,185.00 | 49,393 | |
| ₩2,290.00 | -110.00 | -4.6% | ₩2,355.00 | ₩2,460.00 | ₩2,225.00 | 43,773 | |
| ₩2,400.00 | -80.00 | -3.2% | ₩2,455.00 | ₩2,500.00 | ₩2,345.00 | 48,242 | |
| ₩2,480.00 | -90.00 | -3.5% | ₩2,580.00 | ₩2,615.00 | ₩2,462.00 | 69,574 | |
| ₩2,570.00 | -105.00 | -3.9% | ₩2,745.00 | ₩2,745.00 | ₩2,530.00 | 61,996 | |
| ₩2,675.00 | +135.00 | +5.3% | ₩2,540.00 | ₩2,785.00 | ₩2,540.00 | 109,365 | |
| ₩2,540.00 | -115.00 | -4.3% | ₩2,655.00 | ₩2,655.00 | ₩2,520.00 | 100,336 | |
| ₩2,655.00 | -50.00 | -1.8% | ₩2,675.00 | ₩2,725.00 | ₩2,605.00 | 33,825 | |
| ₩2,705.00 | +160.00 | +6.3% | ₩2,560.00 | ₩2,720.00 | ₩2,545.00 | 45,606 | |
| ₩2,545.00 | -75.00 | -2.9% | ₩2,620.00 | ₩2,660.00 | ₩2,530.00 | 45,451 | |
| ₩2,620.00 | -60.00 | -2.2% | ₩2,675.00 | ₩2,690.00 | ₩2,590.00 | 29,615 | |
| ₩2,680.00 | +10.00 | +0.4% | ₩2,605.00 | ₩2,710.00 | ₩2,580.00 | 91,517 | |
| ₩2,670.00 | -5.00 | -0.2% | ₩2,695.00 | ₩2,750.00 | ₩2,660.00 | 34,984 | |
| ₩2,675.00 | -25.00 | -0.9% | ₩2,725.00 | ₩2,730.00 | ₩2,670.00 | 27,488 | |
| ₩2,700.00 | 0.00 | 0.0% | ₩2,700.00 | ₩2,725.00 | ₩2,670.00 | 36,488 | |
| ₩2,700.00 | -10.00 | -0.4% | ₩2,775.00 | ₩2,775.00 | ₩2,695.00 | 23,586 | |
| ₩2,710.00 | -40.00 | -1.5% | ₩2,740.00 | ₩2,800.00 | ₩2,710.00 | 22,576 | |
| ₩2,750.00 | -15.00 | -0.5% | ₩2,825.00 | ₩2,825.00 | ₩2,690.00 | 41,720 | |
| ₩2,765.00 | +50.00 | +1.8% | ₩2,760.00 | ₩3,220.00 | ₩2,690.00 | 491,981 | |
| ₩2,715.00 | -10.00 | -0.4% | ₩2,725.00 | ₩2,815.00 | ₩2,670.00 | 40,753 | |
| ₩2,725.00 | -20.00 | -0.7% | ₩2,780.00 | ₩2,815.00 | ₩2,700.00 | 40,523 | |
| ₩2,745.00 | -35.00 | -1.3% | ₩2,780.00 | ₩2,780.00 | ₩2,620.00 | 32,239 | |
| ₩2,780.00 | -45.00 | -1.6% | ₩2,825.00 | ₩2,850.00 | ₩2,725.00 | 76,029 | |
| ₩2,825.00 | -80.00 | -2.8% | ₩2,905.00 | ₩2,920.00 | ₩2,750.00 | 80,213 | |
| ₩2,905.00 | +70.00 | +2.5% | ₩2,830.00 | ₩3,040.00 | ₩2,830.00 | 163,347 | |
| ₩2,835.00 | +25.00 | +0.9% | ₩2,810.00 | ₩2,890.00 | ₩2,725.00 | 81,973 | |
| ₩2,810.00 | -90.00 | -3.1% | ₩2,955.00 | ₩2,985.00 | ₩2,800.00 | 124,804 | |
| ₩2,900.00 | -45.00 | -1.5% | ₩3,000.00 | ₩3,295.00 | ₩2,825.00 | 323,086 | |
| ₩2,945.00 | +5.00 | +0.2% | ₩2,940.00 | ₩3,355.00 | ₩2,930.00 | 466,028 | |
| ₩2,940.00 | -290.00 | -9.0% | ₩3,095.00 | ₩3,300.00 | ₩2,830.00 | 502,470 | |
| ₩3,230.00 | +560.00 | +21.0% | ₩2,715.00 | ₩3,470.00 | ₩2,640.00 | 2,656,108 | |
| ₩2,670.00 | — | — | ₩3,190.00 | ₩3,500.00 | ₩2,600.00 | 500,746 |
Splits
2 splits since 2003 · KRX:034940 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-5 | Consolidation | |
| 10-for-1 | Split |
- Ticker
- KRX:034940
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- KRX
- Currency
- KRW
ChoA Pharmaceutical Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
Valuation
EV/sales 0.1× against a median of 1.3×: 2nd lowest of 11 Pharmaceuticals companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩9.22B KRW
- P/E
- Loss
- EV/sales
- 0.1×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.3×
- Gross margin
- 36.9%
- Operating margin
- −6.8%
- Net margin
- −4.6%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| ChoA Pharmaceutical Co., Ltd. · KRX:034940 | US$6.55M | US$6.85M | n/a | 0.1× | n/a | 0.3× | −4.6% | 0.1× | n/a |
| Advicenne SA · EURONEXT:ALDVI | US$10.54M | US$32.08M | n/a | 4.9× | n/a | n/a | −158.7% | n/a | n/a |
| Biofrontera Inc. · NASDAQ:BFRI | US$9.51M | US$13.83M | n/a | 0.3× | n/a | n/a | −12.7% | n/a | 1.96 |
| Optimi Health Corp. · CSE:OPTI | US$9.18M | US$67,059 | n/a | 0.6× | n/a | 0.8× | n/a | 0.0× | 1.08 |
| Newbury Pharmaceuticals AB · OMXSTO:NEWBRY | US$5.78M | US$4.87M | n/a | 1.2× | n/a | 3.0× | −53.7% | 0.0× | n/a |
| Firebrick Pharma Limited · ASX:FRE | US$5.52M | US$4.64M | n/a | 66.0× | n/a | 5.0× | n/a | 0.0× | n/a |
| Universe Pharmaceuticals INC · NASDAQ:UPC | US$5.41M | −US$14.09M | n/a | 0.0× | n/a | 0.1× | −20.6% | 0.2× | 0.91 |
| Mangalam Drugs & Organics Ltd. · NSE:MANGALAM | US$4.71M | US$4.71M | n/a | 0.2× | n/a | 0.4× | −16.5% | 0.0× | n/a |
| Vivimed Labs Limited · NSE:VIVIMEDLAB | US$4.49M | US$46.54M | n/a | 6.2× | n/a | n/a | −252.1% | n/a | n/a |
| Acrux Limited · ASX:ACR | US$4.06M | US$4.60M | n/a | 1.5× | n/a | 4.2× | −13.0% | 1.7× | n/a |
| Scilex Holding Company · NASDAQ:SCLX | US$3.98M | US$98.96M | n/a | 3.1× | n/a | n/a | n/a | n/a | 1.46 |
| Median of the others | US$5.46M | US$4.79M | 1.3× | 1.9× | −20.6% | 0.0× | 1.27 |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 59.3B | 62.7B | 63.0B | 68.9B | 57.6B | 65.4B | 67.5B | 63.1B | 58.9B | 55.6B |
| Cost of revenue | 37.4B | 41.5B | 39.2B | 42.6B | 37.3B | 39.0B | 37.8B | 33.9B | 30.5B | 28.7B |
| Gross profit | 21.9B | 21.2B | 23.8B | 26.2B | 20.3B | 26.4B | 29.7B | 29.1B | 28.4B | 26.8B |
| Research and development | 1.16B | 1.56B | 2.18B | 1.30B | 1.42B | 1.54B | 1.57B | 1.66B | 1.72B | |
| Selling, general and administrative | 8.88B | 28.3B | 27.4B | 24.4B | 24.7B | 25.6B | 27.3B | 25.8B | 25.9B | 24.6B |
| Operating income | -6.60B | -9.70B | -8.82B | -589.3M | -8.94B | -2.72B | -366.4M | 1.33B | 317.7M | -4.83M |
| Depreciation and amortization | 2.43B | 2.21B | 2.22B | 2.24B | 2.89B | 3.05B | 2.81B | 2.11B | 2.10B | 1.84B |
| EBITDA | -4.17B | -7.49B | -6.60B | 1.65B | -6.05B | 333.6M | 2.44B | 3.43B | 2.42B | 1.83B |
| Interest expense | 1.19B | 1.12B | 979.3M | 676.4M | 375.6M | 610.7M | 0 | 0 | 0 | 0 |
| Income before tax | -6.42B | -10.0B | -10.9B | -424.4M | -7.15B | -1.77B | -1.16B | 372.1M | 754.1M | 79.2M |
| Income tax | -161.2M | -33.8M | -244.6M | -623.1M | -34.6M | |||||
| Net income | -6.81B | -9.60B | -10.5B | 560.7M | -8.04B | -1.32B | -905.3M | 641.1M | 1.62B | 163.2M |
| Earnings per share, basic | -1,098.42 | -310.02 | -339.39 | 18.10 | -259.64 | -42.57 | -31.98 | 22.65 | 57.36 | 5.76 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.32B | 1.73M | 2.05B | 27.2M | 19.1M | 4.15B | 10.0B | 10.1B | 10.6B | 2.67B |
| Short-term investments | 198.1M | 3.38B | 2.31B | 2.47B | 4.47B | 4.90B | 4.47B | 1.82B | 1.64B | 3.12B |
| Receivables | 17.8B | 15.1B | 20.2B | 22.7B | 20.9B | 21.5B | 28.1B | 28.4B | 29.0B | 22.0B |
| Inventory | 11.7B | 12.4B | 13.0B | 10.9B | 10.3B | 12.6B | 9.14B | 9.21B | 9.10B | 6.66B |
| Current assets | 35.1B | 39.7B | 42.2B | 48.2B | 46.5B | 47.3B | 53.8B | 53.4B | 52.7B | 44.7B |
| Property, plant and equipment | 19.7B | 20.4B | 25.0B | 24.1B | 22.2B | 21.5B | 20.0B | 19.9B | 21.5B | |
| Goodwill | 0 | 0 | 0 | 0 | 46.8M | 46.8M | ||||
| Total assets | 64.7B | 71.3B | 74.2B | 85.6B | 80.5B | 82.4B | 86.7B | 84.0B | 83.5B | 75.1B |
| Accounts payable | 3.49B | 4.87B | 5.50B | 4.99B | 3.69B | 3.60B | 3.50B | 2.44B | 2.65B | 2.62B |
| Current liabilities | 35.8B | 36.7B | 29.2B | 27.3B | 24.3B | 19.2B | 23.4B | 24.3B | 16.5B | 24.1B |
| Long-term debt | 1.97B | 1.58B | 1.10B | 1.90B | 1.00B | 0 | 3.95B | 1.00B | 8.92B | 0 |
| Total debt | 5.80B | 8.93B | 6.55B | 16.7B | ||||||
| Total liabilities | 42.9B | 39.9B | 35.5B | 32.8B | 30.6B | 24.1B | 33.7B | 30.1B | 29.3B | 27.3B |
| Shareholders' equity | 25.0B | 31.4B | 41.0B | 52.8B | 49.9B | 58.3B | 53.1B | 54.0B | 54.2B | 47.8B |
| Shares outstanding | 6.20M | 31.0M | 31.0M | 31.0M | 31.0M | 31.0M | 28.3M | 28.3M | 28.3M | 28.3M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -4.18B | -4.47B | -1.48B | -1.44B | -1.48B | 1.92B | 4.16B | 2.04B | -675.5M | 930.4M |
| Capital spending | -1.14B | -780.4M | -942.7M | -2.92B | -3.86B | -3.60B | -1.39B | -1.97B | -412.5M | -2.30B |
| Free cash flow | -5.32B | -5.25B | -2.42B | -4.36B | -5.34B | -1.72B | 1.46B | 72.1M | -1.09B | -1.37B |
| Cash from investing | -1.80B | 731.4M | -1.55B | -1.87B | -4.04B | -2.37B | -1.42B | 824.0M | -1.87B | |
| Cash from financing | 6.19B | -1.69B | 1.81B | 4.82B | -3.83B | -2.09B | -1.20B | 7.85B | -598.0M | |
| Share buybacks | 0 | -15.7K | ||||||||
| Change in cash | 227.6M | 50.0M | -2.48B | -1.22B | 1.58B | -5.87B | -100.1M | -441.8M | 7.91B | -1.51B |
Cap table
Built by 6ix from ChoA Pharmaceutical Co., Ltd.’s releases
- Common shares
- 6,195,965
- Fully diluted
- 6,195,965
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 6,195,965 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 6,195,965 |
Log in to ask 6ix AI your own questions about ChoA Pharmaceutical Co., Ltd.